Immune to Cancer: The CRI Blog
-
Cervical Cancer Awareness Month: 2021 Immunotherapy Research Updates
This January for Cervical Cancer Awareness Month, we look at new research, new treatments, and how we’re…
-
CRI ImmunoAdvocate Perspective: Lung Cancer Survivor Oswald Shares His Immunotherapy Experience
CRI ImmunoAdvocate Oswald Peterson discusses his experience receiving a PD-1 checkpoint inhibitor for stage 4 non-small cell…
-
Dr. Kunle Odunsi Answers Questions About Ovarian Cancer and Immunotherapy From the 2020 CRI Virtual Immunotherapy Patient Summit
Dr. Kunle Odunsi of Roswell Park Comprehensive Cancer Center answers questions about ovarian cancer and immunotherapy from…
-
Catching Up on Cancer Research with the CRI Anna-Maria Kellen Clinical Accelerator
Through a variety of efforts, the CRI Clinical Accelerator seeks to advance the next generation of immunotherapies…
-
Dr. Ezra Cohen Answers Questions About Immunotherapy Clinical Trials from the 2020 CRI Virtual Immunotherapy Patient Summit
Dr. Ezra Cohen, of UC San Diego Moores Cancer Center, answers questions about immunotherapy clinical trials from…
-
Immunotherapy: Oswald’s Partner in the Fight
In February 2017, Oswald became one of the first patients to receive pembrolizumab (Keytruda®) as first-line therapy…
-
Ovarian Cancer and Immunotherapy Breakout Session at the 2020 CRI Virtual Immunotherapy Patient Summit
Dr. Kunle Odunsi discusses genomic testing, new treatments, and promising clinical trials in immunotherapy for ovarian cancer.
-
Stomach Cancer Awareness Month: 2020 Immunotherapy Research Updates
This November for Stomach Cancer Awareness Month, we look at new research, new treatments, and how we’re…
-
How Cancer Immunotherapy is Helping Speed a COVID-19 Vaccine
CRI Fellow Susan Klaeger, PhD, is optimizing a method to identify which antigens make the best targets…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.